Brii biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. 2137.hk) is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas.
OPEN腾盛博药在2025年亚太肝病学会年会（APASL）上公布其正在进行的2期ENSURE研究的新数据，表明BRII-179有望通过目标患者识别提高HBsAg清除率 Brii biosciences limited (“brii bio”, stock code Brii biosciences is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas.
